160 related articles for article (PubMed ID: 9622557)
1. Antimalarial cyclic peroxy ketals.
Posner GH; O'Dowd H; Ploypradith P; Cumming JN; Xie S; Shapiro TA
J Med Chem; 1998 Jun; 41(12):2164-7. PubMed ID: 9622557
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
Cumming JN; Wang D; Park SB; Shapiro TA; Posner GH
J Med Chem; 1998 Mar; 41(6):952-64. PubMed ID: 9526569
[TBL] [Abstract][Full Text] [Related]
3. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity.
Posner GH; Oh CH; Wang D; Gerena L; Milhous WK; Meshnick SR; Asawamahasadka W
J Med Chem; 1994 Apr; 37(9):1256-8. PubMed ID: 8176702
[No Abstract] [Full Text] [Related]
4. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Biological Evaluation of Novel 1,2,4-Trioxanes as Potential Antimalarial Agents.
Gupta AK; Varshney K; Kumar V; Srivastava K; Pant AB; Puri SK; Saxena AK
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28207169
[TBL] [Abstract][Full Text] [Related]
6. [Recent advances in the study of artemisinin-related 1,2,4-trioxanes and ozonides (1,2,4-trioxolanes) as antimalarials].
Yang ZS; Li Y
Yao Xue Xue Bao; 2005 Dec; 40(12):1057-63. PubMed ID: 16496665
[No Abstract] [Full Text] [Related]
7. Synthesis and antimalarial activity of some 9-substituted artemisinin derivatives.
Acton N; Karle JM; Miller RE
J Med Chem; 1993 Aug; 36(17):2552-7. PubMed ID: 8355254
[TBL] [Abstract][Full Text] [Related]
8. A QSAR study of the antimalarial activity of some synthetic 1,2,4-trioxanes.
Grigorov M; Weber J; Tronchet JM; Jefford CW; Milhous WK; Maric D
J Chem Inf Comput Sci; 1997; 37(1):124-30. PubMed ID: 9025258
[TBL] [Abstract][Full Text] [Related]
9. Novel ferrocenic artemisinin derivatives: synthesis, in vitro antimalarial activity and affinity of binding with ferroprotoporphyrin IX.
Delhaes L; Blot C; Berry L; Maciejewski LA; Camus D; Brocard JS; Dive D
Bioorg Med Chem; 2000 Dec; 8(12):2739-45. PubMed ID: 11131165
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of the antimalarial agent artemisinin. 2. Effect of heteroatom substitution at O-11: synthesis and bioassay of N-alkyl-11-aza-9-desmethylartemisinins.
Avery MA; Bonk JD; Chong WK; Mehrotra S; Miller R; Milhous W; Goins DK; Venkatesan S; Wyandt C; Khan I
J Med Chem; 1995 Dec; 38(26):5038-44. PubMed ID: 8544180
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimalarial activities of several fluorinated artemisinin derivatives.
Pu YM; Torok DS; Ziffer H; Pan XQ; Meshnick SR
J Med Chem; 1995 Sep; 38(20):4120-4. PubMed ID: 7562948
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of orally active dispiro 1,2,4,5-tetraoxanes; synthetic antimalarials with superior activity to artemisinin.
Amewu R; Stachulski AV; Ward SA; Berry NG; Bray PG; Davies J; Labat G; Vivas L; O'Neill PM
Org Biomol Chem; 2006 Dec; 4(24):4431-6. PubMed ID: 17268634
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and development of novel guaianolide-endoperoxides as potential antimalarial agents.
Sun L; Shah F; Helal MA; Wu Y; Pedduri Y; Chittiboyina AG; Gut J; Rosenthal PJ; Avery MA
J Med Chem; 2010 Nov; 53(21):7864-8. PubMed ID: 20945914
[TBL] [Abstract][Full Text] [Related]
14. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1,2,4-trioxanes like artemisinin.
Posner GH; Wang D; Cumming JN; Oh CH; French AN; Bodley AL; Shapiro TA
J Med Chem; 1995 Jun; 38(13):2273-5. PubMed ID: 7608890
[No Abstract] [Full Text] [Related]
15. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
Rudrapal M; Chetia D
Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based development of new antimalarials: synthesis of derivatives of artemisinin attached to iron chelators.
Kamchonwongpaisan S; Paitayatat S; Thebtaranonth Y; Wilairat P; Yuthavong Y
J Med Chem; 1995 Jun; 38(13):2311-6. PubMed ID: 7608896
[TBL] [Abstract][Full Text] [Related]
17. Syntheses and antimalarial activities of 10-substituted deoxoartemisinins.
Ma J; Katz E; Kyle DE; Ziffer H
J Med Chem; 2000 Nov; 43(22):4228-32. PubMed ID: 11063619
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of the antimalarial agent artemisinin. 4. Effect of substitution at C-3.
Avery MA; Mehrotra S; Bonk JD; Vroman JA; Goins DK; Miller R
J Med Chem; 1996 Jul; 39(15):2900-6. PubMed ID: 8709124
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin.
Posner GH; McGarvey DJ; Oh CH; Kumar N; Meshnick SR; Asawamahasadka W
J Med Chem; 1995 Feb; 38(4):607-12. PubMed ID: 7861408
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, Structure-Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl-1,2,4-Trioxanes as Potent Antiplasmodial as well as Anticancer Agents.
Tiwari MK; Coghi P; Agrawal P; Shyamlal BRK; Jun Yang L; Yadav L; Peng Y; Sharma R; Yadav DK; Sahal D; Kam Wai Wong V; Chaudhary S
ChemMedChem; 2020 Jul; 15(13):1216-1228. PubMed ID: 32392362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
